Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Vascular Therapies, a vascular combination device company, has appointed Samuel Liang as its new president and CEO, effective immediately. Sriram Iyer, the company's founder, will remain as chairman of the board.
Subscribe to our email newsletter
Mr Liang joins Vascular Therapies from Cordis, a Johnson & Johnson company, where most recently he was vice president of worldwide commercial operations.
Mr Liang earned a Masters in management from the Kellogg Graduate School of Management at Northwestern University and a BSE in mechanical engineering and material sciences from Duke University.
Dr Iyer said: “Sam brings wide-ranging experience, both domestic and international, in diversified medical devices and combination products. It’s worth noting that, as worldwide vice president of the Cypher Programs and Global Stent Franchise, he was responsible for all aspects of the company’s drug-eluting stent franchise and initiatives.”